Your browser doesn't support javascript.
loading
The Walter Reed Project, Kisumu Field Station: Impact of Research on Malaria Policy, Management, and Prevention.
Sifuna, Peter M; Mbinji, Michal; Lucas, Tina O; Onyango, Irene; Akala, Hoseah M; Waitumbi, John N; Ogutu, Bernhards R; Hutter, Jack N; Otieno, Walter.
  • Sifuna PM; Kenya Medical Research Institute, Kisumu, Kenya.
  • Mbinji M; U.S. Army Medical Research Directorate-Africa, Kisumu, Kenya.
  • Lucas TO; Kenya Medical Research Institute, Kisumu, Kenya.
  • Onyango I; U.S. Army Medical Research Directorate-Africa, Kisumu, Kenya.
  • Akala HM; Kenya Medical Research Institute, Kisumu, Kenya.
  • Waitumbi JN; U.S. Army Medical Research Directorate-Africa, Kisumu, Kenya.
  • Ogutu BR; Kenya Medical Research Institute, Kisumu, Kenya.
  • Hutter JN; U.S. Army Medical Research Directorate-Africa, Kisumu, Kenya.
  • Otieno W; Kenya Medical Research Institute, Kisumu, Kenya.
Am J Trop Med Hyg ; 110(6): 1069-1079, 2024 Jun 05.
Article en En | MEDLINE | ID: mdl-38653233
ABSTRACT
The Walter Reed Project is a collaboration between the Walter Reed Army Institute of Research of the United States Department of Defense and the Kenya Medical Research Institute. The Kisumu field station, comprising four campuses, has until recently been devoted primarily to research on malaria countermeasures. The Kombewa Clinical Research Center is dedicated to conducting regulated clinical trials of therapeutic and vaccine candidates in development. The center's robust population-based surveillance platform, along with an active community engagement strategy, guarantees consistent recruitment and retention of participants in clinical trials. The Malaria Diagnostic Center, backed by WHO-certified microscopists and a large malaria blood film collection, champions high-quality malaria diagnosis and strict quality assurance through standardized microscopy trainings. The Malaria Drug Resistance Laboratory leverages cutting-edge technology such as real-time Polymerase Chain Reaction (qPCR) to conduct comprehensive research on resistance markers and obtain information on drug efficacy. The laboratory has been working on validating artemisinin resistance markers and improving tracking methods for current and future antimalarial compounds. Finally, the Basic Science Laboratory employs advanced genomic technology to examine endpoints such as immunogenicity and genomic fingerprinting for candidate drugs and vaccine efficacy. Herein, we examine the site's significant contributions to malaria policy, management, and prevention practices in Kenya and around the world.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Malaria Límite: Humans País como asunto: Africa / America do norte Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Malaria Límite: Humans País como asunto: Africa / America do norte Idioma: En Año: 2024 Tipo del documento: Article